As of 6 March 2026, IPO issuance in Hong Kong totals US$11.6 billion year-to-date, compared with US$1.5 billion in the same period in 2025, according to Dealogic – making up 68% of total IPO fundraising in the Asia-Pacific region year-to-date.
The city’s listing pipeline includes prospective issuers from multiple continents and a wide range of sectors, from TMT and consumer to healthcare and industrial.
At the same time, HKEX has been continuing to deepen ties with global exchanges and facilitate cross-listings through its Recognised Stock Exchange list, which encompasses 20 exchanges from 18 countries and opens the door for eligible companies to tap the deep liquidity of Hong Kong’s markets and drive growth.
The activity of international investors is continuing to grow as well. International cornerstone investors have participated in more than three-quarters of IPOs
1 for the year up to 6 March 2026, compared with 63% across all of 2025. They have taken a sizeable role in
the recent surge of AI sector listings – committing nearly 30% of the US$2.5 billion cumulatively raised by AI modeling and training companies Biren Technology, Zhipu, Iluvatar and MiniMax.
For all this and more, the diversity and vibrancy of Hong Kong’s equity and capital markets look set to advance in 2026 and beyond – and HKEX Insight’s ECM Series will explore how in our next instalments.
- Including Hong Kong IPOs with deal size of US$100 million or above.